CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 1 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $523,000 | -44.3% | 33,300 | -62.6% | 0.00% | -50.0% |
| Q3 2015 | $939,000 | -67.3% | 89,062 | -21.8% | 0.00% | -66.7% |
| Q2 2015 | $2,873,000 | +103.5% | 113,893 | +124.8% | 0.01% | +100.0% |
| Q1 2015 | $1,412,000 | +80.8% | 50,666 | +18.5% | 0.00% | +50.0% |
| Q4 2014 | $781,000 | +61.7% | 42,766 | +14.7% | 0.00% | +100.0% |
| Q3 2014 | $483,000 | -72.0% | 37,300 | -64.7% | 0.00% | -80.0% |
| Q2 2014 | $1,725,000 | +123.7% | 105,700 | +142.2% | 0.01% | +150.0% |
| Q1 2014 | $771,000 | -69.2% | 43,644 | -57.8% | 0.00% | -71.4% |
| Q4 2013 | $2,504,000 | +7.6% | 103,444 | +57.4% | 0.01% | -12.5% |
| Q3 2013 | $2,328,000 | +80.7% | 65,715 | -20.4% | 0.01% | +60.0% |
| Q2 2013 | $1,288,000 | +182.5% | 82,515 | +21.3% | 0.01% | +150.0% |
| Q4 2012 | $456,000 | – | 68,015 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Byrne Asset Management LLC | 86 | $2,000 | 0.00% |